News

Avadel’s stock falls 21% after disclosing new FDA request for experimental narcolepsy drug

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News